Clinical Trial Update: Zinc for Infection Prevention in Sickle Cell Anemia-2 (ZIPS-2) [Phase 2, Phase 3]

View source ↗

Summary

The ZIPS-2 trial evaluating zinc for infection prevention in sickle cell disease has completed its Phase 2/Phase 3 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• ZINC (Zinc chloride)

Snippet

Sponsor: Indiana University | Conditions: Sickle Cell Disease | Phase 2, Phase 3 | Status: COMPLETED